Journal of Affective Disorders
Volume 65, Issue 2 , Pages 173-177 , July 2001

Is antidepressant–benzodiazepine combination therapy clinically more useful? A meta-analytic study

  • Toshiaki A. Furukawa

      Affiliations

    • Department of Psychiatry, Nagoya City University Medical School, Mizuho-cho Mizuho-ku, Nagoya 467-8601, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-52-853-8269; fax: +81-52-852-0837
    • ,
  • David L. Streiner

      Affiliations

    • Baycrest Centre for Geriatric Research, University of Toronto, Toronto, Canada
    • ,
  • L.Trevor Young

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada

Received 9 March 2000 ,Accepted 23 May 2000.

References 

  1. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat. Med. 1989;8:141–151
  2. Birkenhager TK, Moleman P, Nolen WA. Benzodiazepines for depression? A review of the literature. Int. Clin. Psychopharmacol. 1995;10:181–195
  3. Dominguez RA, Jacobson AF, Goldstein BJ, Steinbook RM. Comparison of triazolam and placebo in the treatment of insomnia in depressed patients. Curr. Ther. Res. 1984;36:856–865
  4. Fawcett J, Edwards JH, Kravitz HM, Jeffriess H. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam–desipramine combination in the treatment of adult depressed outpatients. J. Clin. Psychopharmacol. 1987;7:295–310
  5. Feet PO, Larsen S, Robak OH. A double blind study in out-patients with primary non-agitated depression treated with imipramine in combination with placebo, diazepam or dixyrazine. Acta Psychiatr. Scand. 1985;72:334–340
  6. Feighner JP, Brauzer B, Gelenberg AJ, Gomez E, Kiev A, Kurland ML, et al. A placebo-controlled multicenter trial of Limbritol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology (Berl.). 1979;61:217–225
  7. Furukawa, T., Streiner, D.L., Young, L.T., 2000. Antidepressant plus benzodiazepine for major depression. In: The Cochrane Library, issue 3. Update Software, Oxford.
  8. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann. Epidemiol. 1995;5:239–244
  9. Nolen WA, Haffmans PMJ, Bouvy PF, Duivenvoorden HJ. Hypnotics as concurrent medication in depression: a placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant. J. Affect. Disord. 1993;28:179–188
  10. Ordonez ACC, Arosamene X, Perez FJO, Herrero CH, Garcia A, Moral L, et al. Clomipramine/bentazepam combination in the treatment of major depressive disorders. Hum. Psychopharmacol. 1992;7:115–122
  11. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. New York: Churchill Livingstone; 1997;
  12. Scharf MB, Hirschowitz J, Zemlan FP, Lichstein M, Woods M. Comparative effects of Limbitrol and amitriptyline on sleep efficiency and architecture. J. Clin. Psychiatry. 1986;47:587–591
  13. Schweizer E, Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr. Scand. Suppl. 1998;393:95–101
  14. Smith WT, Londborg PD, Glaudin V, Painter JR. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am. J. Psychiatry. 1998;155:1339–1345
  15. Thornley B, Adams CE, Awad G. Chlorpromazine versus placebo for those with schizophrenia. In: Cochrane Library. Oxford: Update Software; 1998;
  16. Trindade E, Menon D. Selective Serotonin Reuptake Inhibitors (SSRIS) for Major Depression. Part I: Evaluation of the Clinical Literature (report 3E). Ottawa: Canadian Coordinating Office for Health Technology Assessment; 1997;
  17. Yamaoka K. Augmentation therapy of antidepressant and benzodiazepine in treatment of depression. Seishinka Chiryo-Gaku (in Japanese). 1994;9:1349–1355

PII: S0165-0327(00)00254-8

Journal of Affective Disorders
Volume 65, Issue 2 , Pages 173-177 , July 2001

Article Tools